HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Attenuation of 19-9 antigen secretion in human colorectal carcinoma cell cultures by transfection with cDNA encoding novel ADP-ribosylation factor-like proteins.

Abstract
We have used cDNAs coding for novel ADP-ribosylation factor-like molecules (ARL184 and ARL184Delta) to alter 19-9 antigen glycoprotein secretion in cultured human colorectal carcinoma cells SW1116 by transfection and cloning. This ARL contains a lipophilic N-terminal with an isoleucyl and 3 leucyl residues, 4 functioning consensus sequence GTP binding sites, and 184 total aminoacyl residues. An ARL cDNA was also constructed deleting the codon for the N-terminal glycyl moiety. The resulting cell clones were shown by Northern blots to overexpress ARL mRNA. Electron microscopy-immunocytochemistry also indicated the overexpression of ARL granules subcellularly. Secretion of the tumor-associated 19-9 antigen into apical medium was decreased 3- to 5-fold and the secretion of TCA/PTA precipitable 3H-labeled glycoprotein was decreased by 34% in clone SW1116(ARL184)Delta. Western blot analyses of cell homogenates and media were in agreement with the secretion assays and showed a diminution of 170-200 kDa, 19-9, antigenicity in transfected cells and their media. Apical secretion of 19-9 antigen was diminished 14-fold in cells, SW1116 (ARL184)alpha, transfected with the complete ARL cDNA sequence, suggesting that the glycyl moiety may be required for maximal abatement. However, incorporation of label from [3H]myristate into 22-kDa bands of NP-40 extracts and ARL-antigenic molecules of parent cells was 3-fold greater than that in samples from the two transfectants; thus the transfected cells may not myristylate the overexpressed ARL efficiently. Notwithstanding the N-terminal glycyl moiety undergoing some other modification, we conclude that overexpression of this ARL is sufficient to generate a 19-9-deficient phenotype. These ARLs may eventually disrupt terminal oligosaccharide glycosylation, resulting in an apparent diminished exocytosis of 19-9 glycoprotein carriers by transfected and cloned cells.
AuthorsD Eboue, C Icard-Liepkalns, T M Beringer, V A Liepkalns
JournalArchives of biochemistry and biophysics (Arch Biochem Biophys) Vol. 350 Issue 2 Pg. 145-56 (Feb 15 1998) ISSN: 0003-9861 [Print] United States
PMID9473288 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 1998 Academic Press.
Chemical References
  • Antigens, Neoplasm
  • DNA, Complementary
  • Epitopes
  • Glycoproteins
  • Myristates
  • Neoplasm Proteins
  • Palmitates
  • RNA, Messenger
  • Tretinoin
  • GTP-Binding Proteins
  • ADP-Ribosylation Factors
Topics
  • ADP-Ribosylation Factors
  • Amino Acid Sequence
  • Animals
  • Antigens, Neoplasm (analysis, metabolism)
  • Colorectal Neoplasms (immunology)
  • DNA, Complementary (genetics)
  • Epitopes (immunology)
  • GTP-Binding Proteins (chemistry, genetics)
  • Gene Expression Regulation, Neoplastic (genetics)
  • Glycoproteins (analysis, immunology)
  • Humans
  • Microscopy, Immunoelectron
  • Molecular Sequence Data
  • Myristates (metabolism)
  • Neoplasm Proteins (analysis)
  • Palmitates (metabolism)
  • RNA, Messenger (analysis)
  • Rats
  • Transfection (genetics)
  • Tretinoin (pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: